https://www.politico.eu/article/worlds-first-coronavirus-human-challenge-study-gets-green-light-in-uk/ * Wednesday, February 17, 2021 * Editions + EU Edition + U.K. Edition + U.S. Edition * Events + About POLITICO Events + Future Events * More Info + About Us + Advertising + Content Studio + Press + Print Edition + Contact Us + Jobs + Careers at POLITICO Primary Menu Politico Pro Register Sign In Search for: [ ] Submit Politico Pro * Explore * Subscribe and more * Featured Sections + Brussels + Germany + France + Britain + Migration + Elections in Europe + Defense + Foreign Policy + Poll of Polls + Continent + EU Recovery Plan + Special Reports * Policy Areas + Agriculture and Food + Brexit Transition + Competition and Industrial Policy + Cybersecurity and Data Protection + Energy and Climate + Financial Services + Health Care + Mobility + Sustainability + Technology + Trade + Trade UK * Featured Series + Telescope: AIDS + EU in Africa + Global Policy Lab + Changemakers + Energy Visions + The wonk's survival guide to the EU Green Deal * Columns + The Coming Wars + Europe At Large + World View + Beyond The Bubble + Declassified Events * See all future events * March 4 -- POLITICO's Finance Summit * March 4 -- Playbook Paris interview with Bruno Le Maire, minister of the economy, finance and recovery, France * March 8 -- Virtual Playbook Interviews - Women's day edition * March 9 -- The future of Europe's agri-food production system post-pandemic * March 16 -- Bioeconomy and the Green Deal: matching Europe's climate neutrality and competitiveness goals? Editions * EU Edition * U.K. Edition * U.S. Edition * Newsletters + Brussels Playbook What's driving the day in Brussels + London Playbook What's driving the day in Westminster + EU Influence Campaigning, lobbying and political influence in the EU + London Influence Campaigning, lobbying and political influence in the U.K. + Playbook Paris What's driving the day in Paris, en francais + Sunday Crunch The weekly digest of the best stories in U.K. politics + AI Decoded + Digital Bridge + EU Confidential + Coronavirus Daily Update + EU In Africa * Multimedia + EU Confidential + Westminster Insider + Campaign Confidential + Print Edition + Poll of Polls * our apps + Play Store + App Store * Social Links + Facebook + Twitter + LinkedIn Discover POLITICO Pro In-depth reporting, data and actionable intelligence for policy professionals - all in one place. Five reasons to go Pro Areas of coverage Expert journalists Customers Contact us Hot Topics * Coronavirus in Europe * Brexit * Brussels Playbook * London Playbook * Playbook Paris World's first coronavirus human challenge study gets green light in UK Proponents say these controversial studies provide the fastest way to evaluate new vaccines. TOPSHOT-BRITAIN-HEALTH-VIRUS The initial part of the study will help doctors understand how the immune system reacts to the virus | Tolga Akmen/AFP via Getty Images By Ashleigh Furlong February 17, 2021 1:40 pm * Share on Facebook * Share on Twitter * Share on Linkedin * Mail * Print The U.K. is set to begin the world's first trial of healthy volunteers being intentionally infected with coronavirus, after the study received ethics approval. The so-called human challenge study will begin within a month, said the U.K. Department for Business, Energy and Industrial Strategy in a statement Wednesday, with up to 90 people being exposed to a very small amount of coronavirus in a safe and controlled environment. These kinds of trials are controversial as they expose healthy volunteers to diseases that may be deadly. The next stage of the study, which has not yet been approved, will involve giving a coronavirus vaccine to different volunteers and then exposing them to coronavirus. Only vaccines that "have proven to be safe in clinical trials" will be used. However, researchers are still a "long way" from this stage of the study, according to Terence Stephenson, chair of the Health Research Authority, which gave ethics approval. Proponents say these studies provide the fastest way to evaluate new vaccines, especially when the world emerges from an active pandemic, said Robert Read, head of clinical and experimental sciences within medicine at the University of Southampton, who belongs to this camp and is part of the team involved in the study. This initial part of the study will help doctors understand how the immune system reacts to the virus and identify what affects transmission. The drug Remdesivir will be used as soon as volunteers start developing symptoms. The volunteers, who are being encouraged to come forward for the study, will be between 18 and 30 and will be exposed to the variant circulating in the U.K. since March 2020. This article is part of POLITICO's premium policy service: Pro Health Care. From drug pricing, EMA, vaccines, pharma and more, our specialized journalists keep you on top of the topics driving the health care policy agenda. Email [email protected] for a complimentary trial. More from ... Ashleigh Furlong Most Read Articles * 1 Ireland's toothless travel restrictions exposed as sunseekers take 'dental' holidays February 15, 2021 6:14 pm * 2 World's first coronavirus human challenge study gets green light in UK February 17, 2021 1:40 pm * 3 China topples US as EU's top trade partner over 2020 February 15, 2021 1:30 pm * 4 Inside Slovenia's war on the media February 16, 2021 4:05 am * 5 WHO grants emergency use listing for Oxford/AstraZeneca vaccine February 15, 2021 6:38 pm Discover POLITICO Pro Discover POLITICO Pro In-depth reporting, data and actionable intelligence for policy professionals - all in one place. Find out more Next up Irish politicians face prosecution for lockdown-flouting golf event Irish politicians face prosecution for lockdown-flouting golf event February 17, 2021 8:48 pm By Shawn Pogatchnik Von der Leyen asks Russia why it's selling Sputnik abroad before vaccinating citizens Von der Leyen asks Russia why it's selling Sputnik abroad before vaccinating citizens February 17, 2021 3:38 pm By Jillian Deutsch and David M. Herszenhorn French minister wants inquiry into so-called Islamo-leftist bias in academia French minister wants inquiry into so-called Islamo-leftist bias in academia February 17, 2021 2:12 pm By Jules Darmanin Slovakia and Croatia in talks with Russia over Sputnik coronavirus vaccine Slovakia and Croatia in talks with Russia over Sputnik coronavirus vaccine February 17, 2021 12:13 pm By Helen Collis Related Tags Aid and development Clinical trials Coronavirus Doctors Drug and device safety Environment Hospitals Medicines Pandemic Research Research and Development Vaccines Related Countries United Kingdom Related Organizations Department for Business, Energy and Industrial Strategy Subscribe to POLITICO's Newsletters Subscribe to POLITICO's Newsletters From breaking stories to the insiders track on what is driving the day in Brussels, London and Paris Subscribe today Explore politico EU * Brussels Latest news, analysis and comment from POLITICO's editors and guest writers in Europe. * Germany Latest news, analysis and comment from POLITICO's editors and guest writers on German politics. * France Latest news, analysis and comment from POLITICO's editors and guest writers on French politics. * Elections in Europe Latest news, analysis and comment on elections in Europe and beyond. * Migration Latest news, analysis and comment on migration in Europe and beyond. * Defense Latest news, analysis and comment on defense in Europe and beyond. * Security Latest news, analysis and comment on security in Europe and beyond. * Continent Latest news, analysis and comment from POLITICO's editors and guest writers on the continent. * Policy Areas + Agriculture and Food + Brexit Transition + Competition and Industrial Policy + Cybersecurity and Data Protection + Health Care + Energy and Climate + Financial Services + Mobility + Sustainability + Technology + Trade + Trade UK * Newsletters + Brussels Playbook + London Playbook + Playbook Paris + London Influence + EU Influence + Sunday Crunch + AI Decoded + Ditgital Bridge + EU Confidential + Davos Playbook + Coronavirus Daily Update + EU In Africa Explore Products * Series + Telescope: AIDS + EU in Africa + Global Policy Lab + Changemakers + Energy Visions * Columns + The Coming Wars + Declassified + Europe At Large + World View + Beyond The Bubble * Multimedia + EU Confidential + Westminster Insider + Campaign Confidential + Print Edition + Poll of Polls * our apps + Play Store + App Store * Events Explore the live extension of our journalism * Discover POLITICO Pro In-depth reporting, data and actionable intelligence for policy professionals - all in one place. Politico Logo * About us * Contact us * Privacy Policy * Cookie Policy * Advertising * Press * Print Edition * Jobs * Careers at POLITICO * Ts&Cs * FAQs Close login modal Log in Log in to access content and manage your profile. If you do not have a login you can register here. Log-in [ ] Password [ ] Forgot your password? Click here. [ ] Remember me Log in By logging in, you confirm acceptance of our POLITICO Privacy Policy. Privacy